Tekla Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $7.95M | Buy |
34,434
+21,953
| +176% | +$5.07M | 0.31% | 66 |
|
|
2023
Q1 | $3.02M | Buy |
+12,481
| New | +$3.02M | 0.12% | 99 |
|
|
2021
Q3 | – | Sell |
-13,340
| Closed | -$1.3M | – | 187 |
|
|
2021
Q2 | $1.3M | Hold |
13,340
| – | – | 0.04% | 167 |
|
|
2021
Q1 | $1.56M | Hold |
13,340
| – | – | 0.05% | 170 |
|
|
2020
Q4 | $1.48M | Hold |
13,340
| – | – | 0.05% | 170 |
|
|
2020
Q3 | $1.58M | Hold |
13,340
| – | – | 0.06% | 163 |
|
|
2020
Q2 | $1.51M | Hold |
13,340
| – | – | 0.06% | 177 |
|
|
2020
Q1 | $891K | Hold |
13,340
| – | – | 0.04% | 182 |
|
|
2019
Q4 | $1.22M | Hold |
13,340
| – | – | 0.05% | 177 |
|
|
2019
Q3 | $1.15M | Hold |
13,340
| – | – | 0.05% | 154 |
|
|
2019
Q2 | $1.4M | Hold |
13,340
| – | – | 0.06% | 151 |
|
|
2019
Q1 | $1.67M | Buy |
13,340
+6,670
| +100% | +$836K | 0.07% | 139 |
|
|
2018
Q4 | $752K | Hold |
6,670
| – | – | 0.03% | 175 |
|
|
2018
Q3 | $1.43M | Buy |
+6,670
| New | +$1.43M | 0.05% | 170 |
|
|
2013
Q4 | – | Sell |
-13,993
| Closed | -$3.09M | – | 61 |
|
|
2013
Q3 | $3.09M | Buy |
13,993
+3,229
| +30% | +$713K | 0.34% | 51 |
|
|
2013
Q2 | $1.88M | Buy |
+10,764
| New | +$1.88M | 0.26% | 51 |
|